C. Braggion

1.4k total citations
42 papers, 904 citations indexed

About

C. Braggion is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Emergency Medical Services. According to data from OpenAlex, C. Braggion has authored 42 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 5 papers in Emergency Medical Services. Recurrent topics in C. Braggion's work include Cystic Fibrosis Research Advances (29 papers), Neonatal Respiratory Health Research (10 papers) and Pediatric health and respiratory diseases (5 papers). C. Braggion is often cited by papers focused on Cystic Fibrosis Research Advances (29 papers), Neonatal Respiratory Health Research (10 papers) and Pediatric health and respiratory diseases (5 papers). C. Braggion collaborates with scholars based in Italy, United Kingdom and Germany. C. Braggion's co-authors include G. Mastella, Luisa Zanolla, Ugo Pradal, Guido Polese, Giovanni Taccetti, Roberto Buzzetti, Vito Terlizzi, Enrico Valletta, Muriel Le Bourgeois and K. De Boeck and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

C. Braggion

40 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Braggion Italy 19 703 130 107 84 78 42 904
Margaret F. Guill United States 16 821 1.2× 224 1.7× 155 1.4× 118 1.4× 72 0.9× 39 1.3k
John Massie Australia 20 747 1.1× 104 0.8× 290 2.7× 41 0.5× 69 0.9× 67 1.2k
Mary Corey Canada 14 791 1.1× 124 1.0× 213 2.0× 32 0.4× 90 1.2× 21 1.0k
I. Clifton United Kingdom 18 600 0.9× 238 1.8× 102 1.0× 20 0.2× 72 0.9× 65 901
Joaquim Carlos Rodrigues Brazil 16 572 0.8× 202 1.6× 214 2.0× 30 0.4× 106 1.4× 69 832
Alex H. Gifford United States 19 1.1k 1.6× 257 2.0× 147 1.4× 75 0.9× 94 1.2× 60 1.5k
Melissa Ameloti Gomes Avelino Brazil 17 304 0.4× 165 1.3× 150 1.4× 54 0.6× 59 0.8× 63 736
M B Mearns United Kingdom 17 819 1.2× 173 1.3× 67 0.6× 49 0.6× 101 1.3× 25 1.0k
Concepciόn Prados Spain 17 868 1.2× 192 1.5× 243 2.3× 58 0.7× 56 0.7× 49 1.2k
J Y Paton United Kingdom 15 604 0.9× 88 0.7× 249 2.3× 50 0.6× 77 1.0× 31 1.0k

Countries citing papers authored by C. Braggion

Since Specialization
Citations

This map shows the geographic impact of C. Braggion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Braggion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Braggion more than expected).

Fields of papers citing papers by C. Braggion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Braggion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Braggion. The network helps show where C. Braggion may publish in the future.

Co-authorship network of co-authors of C. Braggion

This figure shows the co-authorship network connecting the top 25 collaborators of C. Braggion. A scholar is included among the top collaborators of C. Braggion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Braggion. C. Braggion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volpi, Sonia, Roberto Buzzetti, Giuseppe Cimino, et al.. (2025). Real-World Safety and Effectiveness of Elexacaftor, Tezacaftor, and Ivacaftor in People with Cystic Fibrosis and Advanced Lung Disease: A Two-Year Multicenter Cohort Study. International Journal of Molecular Sciences. 26(21). 10513–10513.
2.
Salvatore, Donatello, Vincenzo Carnovale, Paola Iacotucci, et al.. (2019). Effectivenesss of ivacaftor in severe cystic fibrosis patients and non‐G551D gating mutations. Pediatric Pulmonology. 54(9). 1398–1403. 16 indexed citations
3.
Terlizzi, Vito, et al.. (2019). Cystic fibrosis screen positive inconclusive diagnosis (CFSPID): Experience in Tuscany, Italy. Journal of Cystic Fibrosis. 18(4). 484–490. 32 indexed citations
4.
Terlizzi, Vito, Antonella Miriam Di Lullo, Marika Comegna, et al.. (2018). S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 44(1). 2–2. 18 indexed citations
5.
Montagnani, Carlotta, P. Cocchi, Laura Lega, et al.. (2015). Serratia marcescens outbreak in a neonatal intensive care unit: crucial role of implementing hand hygiene among external consultants. BMC Infectious Diseases. 15(1). 11–11. 54 indexed citations
6.
Cocchi, P., Giovanni Taccetti, Carlotta Montagnani, et al.. (2013). Evidence of transmission of a Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone: a family affair. Clinical Microbiology and Infection. 19(12). 1158–1162. 10 indexed citations
7.
Kent, Lisa, Philippe Reix, J. A. Innes, et al.. (2013). Lung clearance index: Evidence for use in clinical trials in cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 123–138. 149 indexed citations
8.
Cocchi, P., Lisa Cariani, Antonietta Lambiase, et al.. (2011). Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: A national overview. Journal of Cystic Fibrosis. 10(6). 407–411. 26 indexed citations
9.
Festini, Filippo, et al.. (2009). Parenteral Administration of Tobramycin for Pulmonary Exacerbations in Cystic Fibrosis Patients: Toxicity, Serum Levels and Efficacy. Journal of Chemotherapy. 21(1). 101–104. 3 indexed citations
10.
Festini, Filippo, et al.. (2009). The Costs of Treatment of Early and ChronicPseudomonas aeruginosaInfection in Cystic Fibrosis Patients. Journal of Chemotherapy. 21(2). 188–192. 7 indexed citations
11.
Festini, Filippo, et al.. (2008). Bone mineral density in cystic fibrosis patients under the age of 18 years.. PubMed. 60(2). 147–54. 6 indexed citations
12.
13.
Festini, Filippo, Roberto Buzzetti, C. Braggion, et al.. (2006). Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review. Journal of Hospital Infection. 64(1). 1–6. 44 indexed citations
14.
Valletta, Enrico, et al.. (2001). Early bronchopulmonary involvement in Crohn disease: a case report. BMC Gastroenterology. 1(1). 13–13. 19 indexed citations
15.
Braggion, C., et al.. (1998). Detection of tidal expiratory flow limitation in infants with cystic fibrosis: A pilot study. Pediatric Pulmonology. 25(3). 213–215. 11 indexed citations
16.
17.
Pradal, Ugo, Guido Polese, C. Braggion, et al.. (1994). Determinants of Maximal Transdiaphragmatic Pressure in Adults with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 150(1). 167–173. 25 indexed citations
18.
Valletta, Enrico, et al.. (1993). Sensitization to Aspergillus and Allergic Bronchopulmonary Aspergillosis in a Cystic Fibrosis Population. Pediatric Asthma Allergy & Immunology. 7(1). 43–49. 21 indexed citations
19.
Braggion, C., et al.. (1992). Hemoglobin desaturation during sleep and daytime in patients with cystic fibrosis and severe airway obstruction. Acta Paediatrica. 81(12). 1002–1006. 19 indexed citations
20.
Pradal, Ugo, et al.. (1990). Transcutaneous blood gas analysis during sleep and exercise in cystic fibrosis. Pediatric Pulmonology. 8(3). 162–167. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret F. Guill Breakdown of academic impact, for papers by John Massie Breakdown of academic impact, for papers by Mary Corey Breakdown of academic impact, for papers by I. Clifton Breakdown of academic impact, for papers by Joaquim Carlos Rodrigues Breakdown of academic impact, for papers by Alex H. Gifford Breakdown of academic impact, for papers by Melissa Ameloti Gomes Avelino Breakdown of academic impact, for papers by M B Mearns Breakdown of academic impact, for papers by Concepciόn Prados Breakdown of academic impact, for papers by J Y Paton
Rankless by CCL
2026